Clinical significance of hemophagocytosis in BM clot sections during the peri-engraftment period following allogeneic hematopoietic SCT

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Bone Marrow Transplantation

• Publication date

  2012-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/bmt.2011.95PMID 21499316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Macrophage activation syndrome: advances towards understanding pathogenesis

  2010cited by this paper
• Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy.

  2010cited by this paper
• Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease.

  2009cited by this paper
• Clinicopathological manifestations and treatment of intestinal transplant-associated microangiopathy

  2009cited by this paper
• Human natural killer cells.

  2008cited by this paper
• The phagocytes: neutrophils and monocytes.

  2008cited by this paper
• Long-term follow-up of patients who experienced graft failure postallogeneic progenitor cell transplantation. Results of a single institution analysis.

  2008cited by this paper
• Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients.

  2008cited by this paper
• Encouraging results of low-dose etoposide in the treatment of early-onset hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantation.

  2007cited by this paper
• Hemophagocytic syndromes.

  2007cited by this paper
• Encouraging Results of Low-Dose Etoposide in the Treatment of Early-Onset Hemophagocytic Syndrome Following Allogeneic Hematopoietic Stem Cell Transplantation

  2007cited by this paper
• Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood.

  2006cited by this paper
• Liposomal methylprednisolone differentially regulates the expression of TNF and IL-10 in human alveolar macrophages.

  2005cited by this paper
• Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT.

  2005cited by this paper
• Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival.

  2005cited by this paper
• Tumor necrosis factor-alpha blockade for the treatment of acute GVHD.

  2004cited by this paper
• CD163: a specific marker of macrophages in paraffin-embedded tissue samples.

  2004cited by this paper
• Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft-versus-host disease

  2004cited by this paper
• Counting the cost: markers of endothelial damage in hematopoietic stem cell transplantation

  2004cited by this paper
• Cytokines and chemokines

  2003cited by this paper
• Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation

  2003cited by this paper
• 2. Cytokines and chemokines.

  2003cited by this paper
• Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation.

  2003cited by this paper
• Macrophage inflammatory protein-1.

  2002cited by this paper
• Targeting to macrophages: role of physicochemical properties of particulate carriers--liposomes and microspheres--on the phagocytosis by macrophages.

  2002cited by this paper
• Hemophagocytic syndrome: a rare complication of allogeneic nonmyeloablative hematopoietic stem cell transplantation

  2002cited by this paper
• The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.

  2002cited by this paper
• An overview of the immune system.

  2001cited by this paper
• Engraftment syndrome following hematopoietic stem cell transplantation

  2001cited by this paper
• Macrophages and their subpopulations following allogeneic bone marrow transplantation for chronic myeloid leukaemia

  2000cited by this paper
• Pathophysiologic mechanisms of acute graft-vs.-host disease.

  1999cited by this paper
• Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

  1999cited by this paper
• A reversible posterior leukoencephalopathy syndrome.

  1996cited by this paper
• Inhibitors of haemopoiesis and their potential clinical relevance.

  1995cited by this paper
• 1994 Consensus Conference on Acute GVHD Grading.

  1995cited by this paper
• Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin.

  1991cited by this paper
• Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

  1991cited by this paper
• Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation.

  1990cited by this paper

• Clinical Features of Cytokine Storm Syndrome.

  2024cites this paper
• The macrophage activation marker sCD163 in acute and chronic graft-versus-host disease after pediatric hematopoietic stem cell transplantation

  2023cites this paper
• Characteristics and predictors of post-transplant-associated hemophagocytic lymphohistiocytosis in adults

  2021cites this paper
• Hemophagocytic Lymphohistiocytosis and Graft Failure Following Unrelated Umbilical Cord Blood Transplantation in Children

  2020cites this paper
• Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation

  2019cites this paper
• Macrophage‐mediated complications after stem cell transplantation

  2019cites this paper
• My jamais vu in post allogeneic hematopoietic cell transplant: a review on secondary hemophagocytosis in adults

  2019cites this paper
• Association of Plasma CD163 Concentration with De Novo-Onset Chronic Graft-versus-Host Disease.

  2017cites this paper
• Increase of bone marrow macrophages and CD8+ T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation

  2017cites this paper
• Association of plasma CD 163 concentration with de novo-onset chronic graft-versus-host disease

  2017cites this paper
• Hemophagocytic syndrome following haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide

  2016influential citation
• Dexamethasone palmitate for patients with engraftment syndrome is associated with favorable outcome for children with hematological malignancy

  2016cites this paper
• Steroid Pulse Therapy for Blood Cell Recovery in Allogeneic Hematopoietic Stem Cell Transplantation.

  2016cites this paper
• Cytosine-Phosphorothionate-Guanine Oligodeoxynucleotides Exacerbates Hemophagocytosis by Inducing Tumor Necrosis Factor-Alpha Production in Mice after Bone Marrow Transplantation.

  2016cites this paper
• Phagocytosis by human monocytes is required for the secretion of presepsin.

  2015cites this paper
• Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy

  2012influential citation
• Making sense of the cytokine storm: a conceptual framework for understanding, diagnosing, and treating hemophagocytic syndromes.

  2012cites this paper